Fuwei Yang

542 total citations
16 papers, 397 citations indexed

About

Fuwei Yang is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Fuwei Yang has authored 16 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Epidemiology. Recurrent topics in Fuwei Yang's work include Cancer Mechanisms and Therapy (2 papers), Nanoplatforms for cancer theranostics (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Fuwei Yang is often cited by papers focused on Cancer Mechanisms and Therapy (2 papers), Nanoplatforms for cancer theranostics (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Fuwei Yang collaborates with scholars based in China and United States. Fuwei Yang's co-authors include Yinan Luo, Jingwei Zhao, Pengfei Ge, Hongwei Zhao, Guonan Chi, Boyin Zhang, Donghui Xu, Wenxiang Huang, Yue Gao and Junna Wang and has published in prestigious journals such as PLoS ONE, Chemical Engineering Journal and European Journal of Medicinal Chemistry.

In The Last Decade

Fuwei Yang

15 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuwei Yang China 10 170 63 61 43 40 16 397
Jennifer L. Allensworth United States 7 281 1.7× 50 0.8× 82 1.3× 23 0.5× 132 3.3× 7 493
Linyan Xu China 13 200 1.2× 32 0.5× 46 0.8× 74 1.7× 86 2.1× 44 516
Shivali Duggal India 10 204 1.2× 31 0.5× 55 0.9× 19 0.4× 34 0.8× 13 617
Myron K. Evans United States 7 228 1.3× 38 0.6× 68 1.1× 20 0.5× 106 2.6× 12 425
Yucheng Xiang China 14 253 1.5× 26 0.4× 46 0.8× 34 0.8× 84 2.1× 38 537
Yongzheng Lu China 13 232 1.4× 29 0.5× 84 1.4× 11 0.3× 36 0.9× 22 500
Junying Zheng United States 17 262 1.5× 37 0.6× 74 1.2× 34 0.8× 77 1.9× 28 625
Mateusz Psurski Poland 15 220 1.3× 17 0.3× 44 0.7× 23 0.5× 107 2.7× 50 579
Jingjing Gong China 13 240 1.4× 26 0.4× 102 1.7× 15 0.3× 55 1.4× 28 476

Countries citing papers authored by Fuwei Yang

Since Specialization
Citations

This map shows the geographic impact of Fuwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuwei Yang more than expected).

Fields of papers citing papers by Fuwei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuwei Yang. The network helps show where Fuwei Yang may publish in the future.

Co-authorship network of co-authors of Fuwei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Fuwei Yang. A scholar is included among the top collaborators of Fuwei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuwei Yang. Fuwei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Wang, Yingying, et al.. (2025). New FDA drug approvals for 2024: Synthesis and clinical application. European Journal of Medicinal Chemistry. 285. 117241–117241. 13 indexed citations
3.
Chen, Guangyong, et al.. (2024). Clinical applications of small-molecule GABAAR modulators for neurological disorders. Bioorganic Chemistry. 153. 107983–107983. 1 indexed citations
4.
Yang, Fuwei, et al.. (2024). The journey of p38 MAP kinase inhibitors: From bench to bedside in treating inflammatory diseases. European Journal of Medicinal Chemistry. 280. 116950–116950. 7 indexed citations
5.
Chen, Zhuo, et al.. (2024). The evolution of small-molecule Akt inhibitors from hit to clinical candidate. European Journal of Medicinal Chemistry. 279. 116906–116906. 1 indexed citations
6.
Yang, Fuwei, et al.. (2023). The diagnostic performance of [18F]FET PET/MRI versus [18F]FDG PET/MRI for recurrent glioma: a systematic review and meta-analysis. Clinical and Translational Imaging. 11(3). 285–295. 2 indexed citations
7.
8.
Song, Jun‐Ling, Jing Mao, Weijun Chen, et al.. (2020). A facile synthesis of uniform hollow MIL-125 titanium-based nanoplatform for endosomal esacpe and intracellular drug delivery. Chemical Engineering Journal. 396. 125246–125246. 69 indexed citations
9.
Wang, Junna, et al.. (2019). Metabolic syndrome and liver-related events: a systematic review and meta-analysis. BMC Endocrine Disorders. 19(1). 40–40. 43 indexed citations
10.
Yang, Fuwei, et al.. (2019). The value of severe vitamin D deficiency in predicting the mortality risk of patients with liver cirrhosis: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 43(6). 722–729. 17 indexed citations
11.
Chi, Guonan, Donghui Xu, Boyin Zhang, & Fuwei Yang. (2019). Matrine induces apoptosis and autophagy of glioma cell line U251 by regulation of circRNA-104075/BCL-9. Chemico-Biological Interactions. 308. 198–205. 55 indexed citations
12.
Chen, Guangyong, et al.. (2019). Snail expression contributes to temozolomide resistance in glioblastoma.. PubMed. 11(7). 4277–4289. 11 indexed citations
13.
Luo, Yinan, et al.. (2013). Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1. PLoS ONE. 8(6). e66326–e66326. 123 indexed citations
14.
15.
Ge, Pengfei, Jingwei Zhao, Shulei Li, et al.. (2012). Inhalation of hydrogen gas attenuates cognitive impairment in transient cerebral ischemia via inhibition of oxidative stress. Neurological Research. 34(2). 187–194. 21 indexed citations
16.
Liu, Zhifeng, Fuwei Yang, Dawei Zhai, Chunmei Li, & Ke Liu. (2006). A2. The Gisenoside compound k could increase contraction force of isolated toad heart. Journal of Molecular and Cellular Cardiology. 40(6). 885–886. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer L. Allensworth Breakdown of academic impact, for papers by Linyan Xu Breakdown of academic impact, for papers by Shivali Duggal Breakdown of academic impact, for papers by Myron K. Evans Breakdown of academic impact, for papers by Yucheng Xiang Breakdown of academic impact, for papers by Yongzheng Lu Breakdown of academic impact, for papers by Junying Zheng Breakdown of academic impact, for papers by Mateusz Psurski Breakdown of academic impact, for papers by Jingjing Gong
Rankless by CCL
2026